End-of-day quote
Taipei Exchange
23:00:00 21/05/2024 BST
|
5-day change
|
1st Jan Change
|
422.5
TWD
|
+2.80%
|
|
+11.77%
|
+120.92%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
7,528
|
26,600
|
Enterprise Value (EV)
1 |
6,446
|
22,909
|
P/E ratio
|
-25.1
x
|
-48.5
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
587
x
|
683
x
|
EV / Revenue
|
503
x
|
588
x
|
EV / EBITDA
|
-21.3
x
|
-46.4
x
|
EV / FCF
|
-37,680,260
x
|
-85,994,424
x
|
FCF Yield
|
-0%
|
-0%
|
Price to Book
|
6.48
x
|
7.12
x
|
Nbr of stocks (in thousands)
|
122,910
|
139,084
|
Reference price
2 |
61.25
|
191.2
|
Announcement Date
|
21/04/23
|
04/03/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
18.65
|
10.35
|
12.34
|
12.82
|
38.93
|
EBITDA
1 |
-106.7
|
-76.72
|
-161.4
|
-302.4
|
-493.7
|
EBIT
1 |
-122.1
|
-87.89
|
-177.6
|
-319.6
|
-513.5
|
Operating Margin
|
-654.87%
|
-849.16%
|
-1,439.72%
|
-2,493.17%
|
-1,318.88%
|
Earnings before Tax (EBT)
1 |
-121.8
|
-98.4
|
-224.3
|
-286.2
|
-488.5
|
Net income
1 |
-121.8
|
-98.49
|
-224.3
|
-286.2
|
-488.5
|
Net margin
|
-653.27%
|
-951.56%
|
-1,817.76%
|
-2,232.1%
|
-1,254.64%
|
EPS
2 |
-1.743
|
-0.9247
|
-1.707
|
-2.443
|
-3.943
|
Free Cash Flow
|
-
|
-
|
-29.73
|
-171.1
|
-266.4
|
FCF margin
|
-
|
-
|
-240.91%
|
-1,334.34%
|
-684.26%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/22
|
23/09/22
|
23/09/22
|
21/04/23
|
04/03/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
134
|
42.4
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
547
|
1,083
|
3,691
|
Leverage (Debt/EBITDA)
|
-1.254
x
|
-0.5527
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-29.7
|
-171
|
-266
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-64.9%
|
-31.6%
|
-19.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-23.5%
|
-20.5%
|
-12.7%
|
Assets
1 |
-
|
-
|
953.8
|
1,394
|
3,850
|
Book Value Per Share
2 |
-0.1300
|
0.4400
|
6.020
|
9.460
|
26.90
|
Cash Flow per Share
2 |
0.3100
|
0.8300
|
5.450
|
5.320
|
24.60
|
Capex
|
-
|
2.31
|
14.9
|
14.2
|
8.6
|
Capex / Sales
|
-
|
22.29%
|
120.79%
|
110.48%
|
22.09%
|
Announcement Date
|
10/11/22
|
23/09/22
|
23/09/22
|
21/04/23
|
04/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +120.92% | 1.82B | | +38.86% | 723B | | +34.28% | 595B | | -3.24% | 369B | | +20.82% | 332B | | +2.94% | 282B | | +17.25% | 244B | | +9.24% | 208B | | -4.79% | 205B | | -0.03% | 168B |
Other Pharmaceuticals
|